Trinity Biotech | TRIB - Loan Capital


Trinity Biotech reported $16.33M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Bayer EUR 31.16B 480M Jun/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
EDAP TMS EUR 17.6M 16.6M Mar/2026
J&J USD 37.34B 183M Jun/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 25.22B 2.21B Jun/2026
Siemens EUR 41.32B 199M Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Tosoh JPY 96.02B 11.78B Jun/2026
Trinity Biotech USD 16.33M 98.53M Dec/2025
Veracyte USD 0 0 Mar/2025